An executive at AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference over the weekend could represent $10 billion worth of company sales in five years’ time.
Source: MarketWatch
Tuesday, 21. October 2025
Share:
20. October 2025 12:53
AstraZeneca hails major breakthroughs with breast-cancer drugs
